NASDAQ:MASS 908 Devices (MASS) Stock Price, News & Analysis $5.79 +0.24 (+4.32%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$5.59▼$5.9350-Day Range$4.61▼$6.8552-Week Range$4.57▼$12.51Volume141,627 shsAverage Volume177,559 shsMarket Capitalization$199.70 millionP/E RatioN/ADividend YieldN/APrice Target$14.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get 908 Devices alerts: Email Address 908 Devices MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside141.8% Upside$14.00 Price TargetShort InterestBearish5.41% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment-0.01Based on 11 Articles This WeekInsider TradingAcquiring Shares$178,500 Bought Last QuarterProj. Earnings GrowthGrowingFrom ($1.13) to ($0.99) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.61 out of 5 starsMedical Sector455th out of 936 stocksMeasuring & Controlling Devices, Not Elsewhere Classified Industry6th out of 9 stocks 3.5 Analyst's Opinion Consensus Rating908 Devices has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst Coverage908 Devices has only been the subject of 1 research reports in the past 90 days.Read more about 908 Devices' stock forecast and price target. Previous Next 1.0 Short Interest Percentage of Shares Shorted5.41% of the float of 908 Devices has been sold short.Short Interest Ratio / Days to Cover908 Devices has a short interest ratio ("days to cover") of 5.7.Change versus previous monthShort interest in 908 Devices has recently increased by 10.48%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend Yield908 Devices does not currently pay a dividend.Dividend Growth908 Devices does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for MASS. Previous Next 1.7 News and Social Media Coverage News Sentiment908 Devices has a news sentiment score of -0.01. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.62 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 11 news articles for 908 Devices this week, compared to 2 articles on an average week.MarketBeat Follows2 people have added 908 Devices to their MarketBeat watchlist in the last 30 days. Previous Next 5.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, 908 Devices insiders have bought more of their company's stock than they have sold. Specifically, they have bought $178,500.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders27.80% of the stock of 908 Devices is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions88.06% of the stock of 908 Devices is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about 908 Devices' insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for 908 Devices are expected to grow in the coming year, from ($1.13) to ($0.99) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of 908 Devices is -5.41, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of 908 Devices is -5.41, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share Ratio908 Devices has a P/B Ratio of 1.13. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about 908 Devices' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad American Hartford Gold GroupPrepare for a Recession Unlike Any OtherDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.GET THE FREE GUIDE About 908 Devices Stock (NASDAQ:MASS)908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.Read More MASS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MASS Stock News HeadlinesJuly 27 at 2:01 AM | msn.comMassachusetts new gun bill bans possession of ‘Glock switches’ that turn pistols into machine gunsJuly 26 at 8:11 AM | msn.comMassachusetts governor signs bill cracking down on hard-to-trace 'ghost guns'July 27, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.July 23, 2024 | finance.yahoo.comSpryte Medical Receives Breakthrough Device Designation from FDA for Revolutionary neuro Optical Coherence Tomography (nOCT) TechnologyJuly 22, 2024 | americanbankingnews.comLeerink Partnrs Research Analysts Decrease Earnings Estimates for 908 Devices Inc. (NASDAQ:MASS)July 20, 2024 | 9to5mac.comApple @ Work: How Apple protects the Mac from mass enterprise outagesJuly 20, 2024 | msn.comBill cracking down on ‘ghost guns’ on its way to Mass. Gov. Healey’s deskJuly 20, 2024 | ca.finance.yahoo.comMASS Aug 2024 15.000 callJuly 27, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.June 25, 2024 | businesswire.com908 Devices Appoints Michele M. Leonhart, Former Administrator of the United States Drug Enforcement Administration (DEA), to Its Board of DirectorsJune 18, 2024 | businesswire.com908 Devices Enhances XplorIR Portable Analyzer to Simultaneously Identify and Quantify Hazardous Gases and VaporsMay 29, 2024 | msn.comMassachusetts governor asks feds to ban device that delivers painful shocks to disabled studentsMay 22, 2024 | msn.comMassachusetts medical device company agrees to plead guilty, pay $42M to resolve criminal chargesMay 22, 2024 | msn.comFDA considers ban on device used at Mass. school that delivers shocks to people with disabilitiesMay 15, 2024 | businesswire.com908 Devices to Participate in Upcoming Investor ConferencesMay 14, 2024 | finance.yahoo.comWall Street Analysts Predict a 133.69% Upside in 908 Devices (MASS): Here's What You Should KnowMay 1, 2024 | finance.yahoo.com908 Devices Inc. (NASDAQ:MASS) Q1 2024 Earnings Call TranscriptMay 1, 2024 | bizjournals.comFive things: Kendall construction suit, Bay State Banner, Boston Dynamics and the best time to visit Mount Auburn CemeterySee More Headlines Receive MASS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for 908 Devices and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/30/2024Today7/26/2024Next Earnings (Confirmed)8/06/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Measuring & controlling devices, not elsewhere classified Sub-IndustryMeasuring And Control Equipment Current SymbolNASDAQ:MASS CUSIPN/A CIK1555279 Webwww.908devices.com Phone857-254-1500FaxN/AEmployees60Year FoundedN/APrice Target and Rating Average Stock Price Target$14.00 High Stock Price Target$14.00 Low Stock Price Target$14.00 Potential Upside/Downside+141.8%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($1.07) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-36,400,000.00 Net Margins-68.57% Pretax Margin-69.12% Return on Equity-20.87% Return on Assets-17.13% Debt Debt-to-Equity RatioN/A Current Ratio8.37 Quick Ratio7.53 Sales & Book Value Annual Sales$50.23 million Price / Sales3.98 Cash FlowN/A Price / Cash FlowN/A Book Value$5.11 per share Price / Book1.13Miscellaneous Outstanding Shares34,490,000Free Float24,898,000Market Cap$199.70 million OptionableOptionable Beta1.01 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key ExecutivesDr. Kevin J. Knopp Ph.D. (Age 51)Co-Founder, CEO, President & Director Comp: $761.12kMr. Joseph H. Griffith IV (Age 49)CFO & Treasurer Comp: $491.89kMr. Michael S. Turner Esq. (Age 57)J.D., Chief Legal & Administrative Officer and Secretary Comp: $470.65kDr. Christopher David Brown Ph.D. (Age 49)Co-Founder, Chief Product Officer & Co-Chair of Scientific Advisory Board Comp: $459.7kMr. Steve AraizaCo-FounderMr. Andrew BartfayCo-Founder & Director of Hardware DevelopmentMr. Michael JobinCo-Founder & Director of Product DevelopmentDr. Scott Miller Ph.D.Co-Founder & Director of MS EngineeringMs. Barbara Russo (Age 61)Vice President of Marketing & Corporate Communications Mr. Don Osmer (Age 58)Vice President of Human Resources More ExecutivesKey CompetitorsQuanterixNASDAQ:QTRXEyePoint PharmaceuticalsNASDAQ:EYPTNautilus BiotechnologyNASDAQ:NAUTSenseonicsNYSE:SENSQuantum-SiNASDAQ:QSIView All CompetitorsInsiders & InstitutionsARK Investment Management LLCSold 111,307 shares on 7/26/2024Ownership: 11.417%Bank of New York Mellon CorpBought 4,212 shares on 7/26/2024Ownership: 0.202%Sumitomo Mitsui Trust Holdings Inc.Sold 66,492 shares on 7/19/2024Ownership: 1.438%GAMMA Investing LLCBought 9,254 shares on 7/2/2024Ownership: 0.027%AWM Investment Company Inc.Bought 15,058 shares on 5/16/2024Ownership: 1.939%View All Insider TransactionsView All Institutional Transactions MASS Stock Analysis - Frequently Asked Questions How have MASS shares performed this year? 908 Devices' stock was trading at $11.22 at the beginning of the year. Since then, MASS stock has decreased by 48.4% and is now trading at $5.79. View the best growth stocks for 2024 here. How were 908 Devices' earnings last quarter? 908 Devices Inc. (NASDAQ:MASS) released its earnings results on Tuesday, April, 30th. The company reported ($0.33) EPS for the quarter, beating analysts' consensus estimates of ($0.36) by $0.03. 908 Devices's revenue for the quarter was up 5.3% compared to the same quarter last year. When did 908 Devices IPO? 908 Devices (MASS) raised $101 million in an IPO on Friday, December 18th 2020. The company issued 6,300,000 shares at a price of $15.00-$17.00 per share. Cowen, SVB Leerink, Stifel and William Blair served as the underwriters for the IPO. Who are 908 Devices' major shareholders? 908 Devices' top institutional investors include ARK Investment Management LLC (11.42%), Sumitomo Mitsui Trust Holdings Inc. (1.44%), Bank of New York Mellon Corp (0.20%) and GAMMA Investing LLC (0.03%). Insiders that own company stock include Christopher D Brown, Kevin J Knopp, Joseph H Iv Griffith, Trent A Basarsky, Mark Spoto, Michael S Turner and John Kenneweg. View institutional ownership trends. How do I buy shares of 908 Devices? Shares of MASS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:MASS) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredJ.P. Morgan’s DIRE WarningWhen the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal war...Behind the Markets | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 908 Devices Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share 908 Devices With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
